When Standard Toxicology Is Not Enough
Standard toxicology panels performed during autopsy typically screen for common drugs of abuse, prescription medications, alcohol, and a limited range of toxic substances. While this testing identifies the cause of death in many drug-related cases, there are situations where standard testing falls short. Advanced forensic toxicology employs specialized techniques to detect substances that evade routine screening, quantify drug concentrations with greater precision, and interpret complex toxicological findings in the context of postmortem changes.
For families seeking comprehensive answers about whether drugs, poisons, or environmental toxins contributed to their loved one’s death, understanding the capabilities and limitations of toxicology testing is essential.
What Standard Toxicology Covers
A standard postmortem toxicology panel typically includes screening and confirmation for several categories of substances:
- Alcohol: Ethanol (drinking alcohol) in blood, urine, and vitreous humor, along with other alcohols such as methanol and isopropanol
- Common drugs of abuse: Opioids (heroin, fentanyl, oxycodone, morphine), cocaine and metabolites, amphetamines and methamphetamine, benzodiazepines, cannabis (THC), phencyclidine (PCP), and barbiturates
- Prescription medications: Antidepressants, antipsychotics, anticonvulsants, cardiac medications, and other commonly prescribed drugs
- Over-the-counter medications: Acetaminophen, diphenhydramine (Benadryl), dextromethorphan, and other OTC drugs
- Carbon monoxide: Carboxyhemoglobin levels in blood
Standard panels typically screen 200 to 400 substances and employ immunoassay screening followed by confirmation using gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Advanced Toxicology Testing
Novel Psychoactive Substances (NPS)
The rapidly evolving landscape of synthetic drugs presents a major challenge for forensic toxicology. Novel psychoactive substances, sometimes called “designer drugs” or “research chemicals,” are synthetic compounds engineered to mimic the effects of traditional drugs of abuse while evading detection by standard testing panels. These include synthetic cannabinoids (such as K2 and Spice), synthetic cathinones (bath salts), novel benzodiazepines not used in clinical medicine, and novel synthetic opioids beyond fentanyl.
Detecting NPS requires specialized reference standards and updated analytical methods that many routine toxicology laboratories may not have. Families who suspect NPS involvement should request that samples be sent to a reference laboratory with expertise in emerging drugs.
Fentanyl Analogs
The fentanyl crisis has produced dozens of analog compounds, each with slightly different chemical structures and potencies. While standard panels now typically include fentanyl, many analogs such as carfentanil, acetylfentanyl, fluorofentanyl, and nitazenes require specific testing. Given the extreme potency of some analogs (carfentanil is approximately 100 times more potent than fentanyl), even trace amounts can be lethal and require sensitive analytical methods for detection.
Heavy Metals and Poisoning
Heavy metal poisoning is not included in standard toxicology panels and requires specific testing using inductively coupled plasma mass spectrometry (ICP-MS) or atomic absorption spectroscopy. Substances that may be tested include arsenic, which is historically one of the most common homicidal poisons due to its delayed onset and nonspecific symptoms; lead, relevant in cases of chronic exposure or acute ingestion; mercury, both organic and inorganic forms; thallium, a highly toxic metal that causes hair loss and peripheral neuropathy; and antimony, cadmium, and chromium in occupational exposure cases.
Heavy metal testing is particularly important when poisoning is suspected, when the deceased had unexplained chronic illness before death, or when environmental or occupational exposure may have contributed to the death.
Volatile Substances
Standard alcohol testing may not include all volatile compounds that can cause death. Advanced volatile analysis can identify substances including chloroform, ether, and other anesthetic agents; industrial solvents such as toluene, benzene, and trichloroethylene; gases such as hydrogen sulfide, cyanide, and propane; and inhalant abuse substances such as nitrous oxide, butane, and difluoroethane (found in compressed air dusters).
Volatile substance analysis requires specialized headspace gas chromatography techniques and should be performed on blood samples collected in airtight containers to prevent evaporation of the target compounds.
Pharmaceutical Compounding Errors
When death is suspected to have resulted from a medication error, specifically wrong concentration or contaminated compounded medication, advanced testing can quantify the exact drug concentration in the medication and compare it to the labeled strength. This type of analysis may involve testing both the biological samples from the deceased and the medication itself.
Plant and Natural Toxins
Standard toxicology panels do not screen for most plant-derived toxins, mushroom toxins, or naturally occurring poisons. Specialized testing can detect substances including aconitine from monkshood (Aconitum), oleandrin from oleander, ricin from castor beans, amatoxin from death cap mushrooms (Amanita phalloides), tetrodotoxin from puffer fish, and colchicine from autumn crocus. These tests are typically requested when the circumstances of death suggest exposure to a specific plant or natural toxin.
Specimen Selection for Advanced Testing
The choice of specimen for toxicology testing significantly affects the quality and interpretability of results. Different specimens provide different types of information:
- Femoral blood: The preferred specimen for quantitative drug analysis because it is less affected by postmortem redistribution than blood from central sites (heart). Drug concentrations in femoral blood most closely reflect concentrations at the time of death
- Vitreous humor: The fluid from the eye is relatively isolated from postmortem decomposition and microbial activity, making it valuable for alcohol, glucose, and electrolyte analysis. It is also less subject to postmortem contamination
- Urine: Provides information about recent drug use but not the concentration present at the time of death. Useful for detecting drug metabolites that may not be present in blood
- Bile: Concentrates certain drugs and can be useful when blood levels are too low for detection. Particularly valuable for detecting opioids and benzodiazepines
- Liver tissue: Serves as a reservoir for many drugs and can be analyzed when blood is unavailable or decomposed. Liver drug concentrations can help distinguish acute from chronic exposure
- Hair: Provides a chronological record of drug exposure over weeks to months. Each centimeter of hair growth represents approximately one month of exposure history. Hair testing cannot determine the dose or timing precisely but can establish a pattern of use
- Gastric contents: Can identify recently ingested drugs or poisons, including pills or capsules that had not yet been fully absorbed. Particularly important in suspected oral poisoning cases
- Bone marrow: Can be tested in highly decomposed or skeletonized remains when other specimens are unavailable
Postmortem Redistribution
One of the most important concepts in forensic toxicology is postmortem redistribution (PMR), the process by which drug concentrations change in the body after death. Understanding PMR is essential for accurately interpreting toxicology results.
After death, drugs stored in organs like the liver, lungs, and heart can diffuse into surrounding blood, artificially elevating blood drug concentrations. This is particularly significant for lipophilic (fat-soluble) drugs such as tricyclic antidepressants, methadone, propoxyphene, and digoxin. Cardiac blood is most affected by PMR because of its proximity to drug-rich organs. This is why femoral (leg) blood is preferred for quantitative analysis, as it is farther from the organs that release drugs after death.
PMR means that a postmortem drug level cannot be directly compared to clinical therapeutic ranges. A concentration that would be considered “toxic” in a living patient may be within normal postmortem range for a therapeutic user. Interpreting postmortem drug levels requires expertise in forensic toxicology and consideration of the specific drug, the specimen site, the time since death, and the degree of decomposition.
Requesting Advanced Toxicology Testing
If you believe advanced toxicology testing is needed in your loved one’s case, there are several steps to consider:
- Speak with the pathologist: Discuss your concerns with the forensic pathologist who performed or will perform the autopsy. They can recommend specific tests based on the circumstances of the death and ensure appropriate specimens are collected and preserved
- Request sample retention: Ask that all collected specimens be retained for potential future testing. Properly preserved blood, urine, and tissue samples can be tested months or even years after collection
- Contact a reference laboratory: National reference laboratories such as NMS Labs, USDTL, and Axis Forensic Toxicology offer comprehensive testing panels and can advise on which tests are most appropriate for your situation
- Consult a forensic toxicologist: An independent forensic toxicologist can review existing results, recommend additional testing, and provide expert interpretation of complex findings. This is particularly valuable when toxicology results need to be presented in legal proceedings
- Preserve the chain of custody: If the results may be used in legal proceedings, ensure that proper chain of custody documentation is maintained for all specimens
Cost of Advanced Toxicology Testing
Standard postmortem toxicology screening typically costs $500 to $1,500 when included as part of an autopsy. Advanced or specialized testing can add significant costs:
- Novel psychoactive substance panels: $300 to $800 per panel
- Heavy metal screening: $200 to $500 per specimen
- Hair drug testing: $300 to $700
- Volatile substance analysis: $200 to $400
- Individual compound confirmation: $100 to $300 per substance
- Forensic toxicologist expert review: $200 to $500 per hour
When toxicology testing is performed as part of a medical examiner or coroner investigation, the cost is covered by the investigating agency. For private autopsies, families should discuss testing costs upfront and prioritize the tests most likely to yield answers based on the circumstances of the death.
Interpreting Your Toxicology Report
Toxicology reports contain technical information that can be confusing for families. Key concepts to understand include the difference between qualitative results (detected or not detected) and quantitative results (the measured concentration of a substance), the significance of therapeutic versus toxic versus lethal concentration ranges, the role of drug interactions where two or more substances may be individually non-lethal but fatal in combination, and the importance of the specific specimen tested and the potential impact of postmortem redistribution on the reported values.
Families should request a meeting with the forensic pathologist or toxicologist to review the findings. A qualified expert can explain what the results mean in the context of the specific case, whether the substances detected caused or contributed to the death, and whether additional testing might provide further clarity.